跳至主要内容
临床试验/NCT04295616
NCT04295616终止不适用

The Additional Effect of Intrapulmonary Percussive Ventilation (IPV) on Respiration in People With Multiple Sclerosis (MS).

National Multiple Sclerosis Center2 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2020年1月13日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
5
试验地点
2
主要终点
Change in breathing force

研究概览

简要总结

This study aims to investigate whether intrapulmonary percussive ventilation (IPV) in combination with active breathing exercises using the flow-based incentive spirometer (Inspirix) has a positive effect on the respiratory values in people with multiple sclerosis (MS).

详细描述

The primary research question includes "what is the additional effect of intensive IPV treatment in combination with active breathing exercises on respiratory power (Peak Expiratory Flow, PEF) in people with MS?".

In a single-center randomized clinical trial, 96 people with MS-related respiratory problems will be allocated to either the intervention group (IPV + active breathing training) or the control group (active breathing training only). Interventions will be provided by trained speech- and language therapists, in combination with a multidisciplinary rehabilitation programme of 3 weeks. Pre- en posttraining assessment includes measures of respiration, speech and fatigue.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • diagnosis MS
  • inpatient in the National Multiple Sclerosis Center Melsbroek for at least 3 weeks in the period Jan-Dec 2020
  • adequate lip closure
  • adequate cognitive functioning (MMSE>26/30 & clinical observation)
  • Peak Expiratory Flow (PEF) with a cut off score of 80% or lower

排除标准

  • IPV or other breathing treatment of more than 1x/week within 3 months prior to study participation
  • MS relapse within 3 months prior to study participation
  • asthma or Chronic Obstructive Pulmonary Disease (COPD)
  • infection of lower respiratory tract within 6 weeks prior to study participation
  • infection of upper respiratory tract within 2 weeks prior to study participation

结局指标

主要结局

Change in breathing force

时间窗: pre- post (3 weeks) (some participants also at 4 weeks)

Change in Peak Expiratory Flow (PEF)- Maximum flow achieved during a maximum forced exhalation.

次要结局

  • Change in Visual Analogue Scale (VAS) for fatigue(pre- post (3 weeks) (some participants also at 4 weeks))
  • Change in Vital Capacity (VC)(pre- post (3 weeks) (some participants also at 4 weeks))
  • Change in Maximum Phonation time (MFT)(pre- post (3 weeks) (some participants also at 4 weeks))
  • Change in Voice Handicap Index (VHI-10)(pre- post (3 weeks) (some participants also at 4 weeks))
  • Change in Maximum Inspiratory Pressure (MIP)(pre- post (3 weeks) (some participants also at 4 weeks))
  • Change in Maximum Expiratory Pressure (MEP)(pre- post (3 weeks) (some participants also at 4 weeks))
  • Change in Pulmonary Dysfunction Index (PDI)(pre- post (3 weeks) (some participants also at 4 weeks))

研究者

发起方
National Multiple Sclerosis Center
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Additional Effect of Intrapulmonary Percussive... | 临床试验